Stay updated on IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page.

Latest updates to the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about CLDN18.2-positive adenocarcinomas and a new revision number, while significant details about the trial's purpose and inclusion/exclusion criteria have been removed.SummaryDifference10%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.4, indicating a revision in the content.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page.